SCHEMBL21546705

SCHEMBL21546705

Cc1ccccc1-c1ccc2c(c1)c1ccccc1n2-c1cc(C#N)cc(-n2c3ccccc3c3cc(-c4ccccc4C)ccc32)c1-c1cccc(C#N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.37
BRD4 O60885 1/20 0.36
AR P10275 2/20 0.36
PTGER4 P35408 1/20 0.36
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
ALDH1A1 P00352 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
CLK4 Q9HAZ1 3/20 0.33
MEN1 O00255 2/20 0.33
CYP2C19 P33261 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22761061 0.97 ADRA2C (0.39) ADRA2CBRD4ARHTR1AHTR7
SCHEMBL21546687 0.95 ADRA2C (0.36) ADRA2CBRD4ARPTGER4HTR1A
SCHEMBL21414116 0.93 AR (0.38) ARPTGER4ALDH1A1CYP1A2CYP3A4
SCHEMBL25658932 0.91 PTGER4 (0.39) ARPTGER4ALDH1A1HSD17B10RORC
SCHEMBL21546704 0.91 ADRA2C (0.38) ADRA2CBRD4ARHTR1AHTR7
SCHEMBL21929227 0.91 PTGER4 (0.36) ADRA2CBRD4ARPTGER4ALDH1A1
SCHEMBL21546947 0.91 ELANE (0.36) ADRA2CBRD4ARPTGER4ALDH1A1
SCHEMBL21546931 0.90 AR (0.42) ADRA2CBRD4ARPTGER4PDK2
SCHEMBL21546744 0.89 MAP4K4 (0.40) PTGER4ALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL21546716 0.88 ADRA2C (0.38) ADRA2CALDH1A1CYP1A2CYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 US disclosed
EP-3478793-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM ADRA2C 3840/4885BRD4 2909/4885AR 4523/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM ADRA2C 3840/4885BRD4 2909/4885AR 4523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.